These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 25200152)

  • 1. [Mouse macrophage-derived chemokine as an adjuvant enhances the protective effect of P6 protein vaccine of nontypeable Haemophilus influenzae].
    Han X; Wang C; Qiao H; Zhang Y; Chang Y; Zhang Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Sep; 30(9):913-6. PubMed ID: 25200152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of an immunodominant T cell epitope of the P6 protein of nontypeable Haemophilus influenzae in murine protective immunity.
    McMahon M; Murphy TF; Kyd J; Thanavala Y
    Vaccine; 2005 May; 23(27):3590-6. PubMed ID: 15855018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th17 cells contribute to nontypeable Haemophilus influenzae-specific protective immunity induced by nasal vaccination with P6 outer membrane protein and α-galactosylceramide.
    Noda K; Kodama S; Umemoto S; Nomi N; Hirano T; Suzuki M
    Microbiol Immunol; 2011 Aug; 55(8):574-81. PubMed ID: 21605159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization.
    Hotomi M; Ikeda Y; Suzumoto M; Yamauchi K; Green BA; Zlotnick G; Billal DS; Shimada J; Fujihara K; Yamanaka N
    Vaccine; 2005 Jan; 23(10):1294-300. PubMed ID: 15652672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasal immunization with plasmid DNA encoding P6 protein and immunostimulatory complexes elicits nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx.
    Kodama S; Hirano T; Noda K; Umemoto S; Suzuki M
    Vaccine; 2011 Feb; 29(10):1881-90. PubMed ID: 21237276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal vaccination with CpG oligodeoxynucleotide induces protective immunity against non-typeable Haemophilus influenzae in the nasopharynx.
    Abe N; Kodama S; Hirano T; Eto M; Suzuki M
    Laryngoscope; 2006 Mar; 116(3):407-12. PubMed ID: 16540899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae.
    Bertot GM; Becker PD; Guzmán CA; Grinstein S
    J Infect Dis; 2004 Apr; 189(7):1304-12. PubMed ID: 15031801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasal vaccination with P6 outer membrane protein and alpha-galactosylceramide induces nontypeable Haemophilus influenzae-specific protective immunity associated with NKT cell activation and dendritic cell expansion in nasopharynx.
    Noda K; Kodama S; Umemoto S; Abe N; Hirano T; Suzuki M
    Vaccine; 2010 Jul; 28(31):5068-74. PubMed ID: 20478344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal immunization enhances clearance of nontypeable Haemophilus influenzae and reduces stimulation of tumor necrosis factor alpha production in the murine model of otitis media.
    Sabirov A; Kodama S; Hirano T; Suzuki M; Mogi G
    Infect Immun; 2001 May; 69(5):2964-71. PubMed ID: 11292713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single nasal dose of fms-like tyrosine kinase receptor-3 ligand, but not peritoneal application, enhances nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx.
    Kodama S; Hirano T; Noda K; Abe N; Suzuki M
    Vaccine; 2010 Mar; 28(13):2510-6. PubMed ID: 20117272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Concentrations of Antibodies against Outer Membrane Protein P6, Protein D, and T- and B-Cell Combined Antigenic Epitopes of Nontypeable Haemophilus influenzae in Children and Adults of Different Ages.
    Hua CZ; Hu WL; Shang SQ; Li JP; Hong LQ; Yan J
    Clin Vaccine Immunol; 2016 Feb; 23(2):155-61. PubMed ID: 26677200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico design, cloning, expression and immunologic evaluation of ED fusion protein of NT H. influenzae.
    Behrouzi A; Bouzari S; Oloomi M; Fateh A; Vaziri F; Afrough P; Amanzadeh A; Siadat SD
    Microb Pathog; 2017 Dec; 113():472-479. PubMed ID: 29138085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bactericidal antibody response against P6, protein D, and OMP26 of nontypeable Haemophilus influenzae after acute otitis media in otitis-prone children.
    Khan MN; Kaur R; Pichichero ME
    FEMS Immunol Med Microbiol; 2012 Aug; 65(3):439-47. PubMed ID: 22463053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant C-terminal 311 amino acids of HapS adhesin as a vaccine candidate for nontypeable Haemophilus influenzae: A study on immunoreactivity in Balb/C mouse.
    Tabatabaee Bafroee AS; Siadat SD; Mousavi SF; Aghasadeghi MR; Khorsand H; Nejati M; Sadat SM; Mahdavi M
    Microb Pathog; 2016 Sep; 98():106-11. PubMed ID: 27377430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529.
    Mason KW; Zhu D; Scheuer CA; McMichael JC; Zlotnick GW; Green BA
    Vaccine; 2004 Sep; 22(25-26):3449-56. PubMed ID: 15308371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and immunogenicity evaluation of C-HapS-P6 fusion protein vaccine against nontypeable Haemophilus influenzae in mice.
    Hu N; Li W; Zhao Z; Chang Y; Wang C; Zhang Y
    Int J Med Microbiol; 2024 Mar; 314():151616. PubMed ID: 38461565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal intranasal immunization with outer membrane protein P6 maintains specific antibody level of derived offspring.
    Yamauchi K; Hotomi M; Billal DS; Suzumoto M; Yamanaka N
    Vaccine; 2006 Jun; 24(25):5294-9. PubMed ID: 16697503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal immunization with recombinant outer membrane protein P6 induces specific immune responses against nontypeable Haemophilus influenzae.
    Hotomi M; Yamanaka N; Shimada J; Suzumoto M; Ikeda Y; Sakai A; Arai J; Green B
    Int J Pediatr Otorhinolaryngol; 2002 Sep; 65(2):109-16. PubMed ID: 12176180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization of mice with P6 of nontypeable Haemophilus influenzae: kinetics of the antibody response and IgG subclasses.
    Badr WH; Loghmanee D; Karalus RJ; Murphy TF; Thanavala Y
    Vaccine; 1999 Aug; 18(1-2):29-37. PubMed ID: 10501232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of lipid modification on the physicochemical, structural, antigenic and immunoprotective properties of Haemophilus influenzae outer membrane protein P6.
    Yang YP; Munson RS; Grass S; Chong P; Harkness RE; Gisonni L; James O; Kwok Y; Klein MH
    Vaccine; 1997 Jun; 15(9):976-87. PubMed ID: 9261944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.